🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A recent commentary in bioRxiv discussed data analysis for our mtDNA-based lineage tracing technology ReDeeM. We welcome the points raised and are happy to address these concerns. We believe this will foster constructive dialogue (1/n) doi.org/10.1101/2024.0…

I am thrilled to announce that I have been selected by ASH to receive the 2024 ASH Global Research Award! #ASHAwards So excited to explore new avenues and deeply thankful for the outstanding support from my institution and mentors!

It has been a pleasure and honor to spend the last two months in Vijay Sankaran’ lab at Boston Children’s Hospital. New friends and wonderful human beings. Thank you for hosting me, it has been truly inspiring and motivating!

I can smell it in the air, THAT time of the year is coming! 😍 Welcome to the 2024 ESGCT Annual Meeting, this year in an amazing venue in #Rome! Welcome back #home, welcome to #Italy! 🇮🇹 So excited to share our latest results and meet you all!✌🏻

Excited to present the work of Martina Fiumara and the whole team at ASH in the poster session today. Thanks to #omics and #CRISPR editing we discovered the mechanism of clonal dominance and BMF in #VEXAS syndrome. See you there!

Thank you, Alejo!!

Analyses of single-cell transcriptomic data from patients with VEXAS syndrome combined with xenotransplant experiments in a mouse model of the disease provide insights on the mechanisms of clonal dominance of mutated cells leading to bone marrow failure. nature.com/articles/s4159…

Wow!!! 🤯 Amazing, Oriol Pich, Elsa Bernard, Elli Papaemmanuil, PhD, Charles Swanton, and team! nejm.org/doi/full/10.10…